Research Projects & Grants

For Profit Organization

• A Phase 2/3 Randomized, Placebo-Controlled, Double-blind, Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants with Heart Failure due to Systemic Left Ventricular Systolic Dysfunction (VALOR), Role: Investigator, Merck, (03/2025 - 03/2026) Status: Approved

Internal

• Low absolute lymphocyte count associated with anti-thymocyte globulin induction may be a predictor of early cytomegalovirus infection in pediatric heart transplantation, Role: PI, LLU Dept. of Pediatrics, (08/2024) Status: Approved
• Interventions in children post-heart transplant, Role: PI, LLU Dept. of Pediatrics, (06/2024) Status: Approved
• Pediatric heart transplant study group collaborative database, Role: Investigator, LLU Dept. of Pediatrics, (03/2025 - 03/2026) Status: Approved
• Normalization of hemodynamics after pediatric heart transplant, Role: PI, LLU Dept. of Pediatrics, (04/2023) Status: Approved
• Advanced cardiac therapies improving outcomes network to improve the health of pediatric and congenital heart disease patients with heart failure, Role: Investigator, LLU Dept. of Pediatrics, (12/2019) Status: Approved
• Selexipag for pulmonary hypertension in children of all ages, Role: PI, LLU Dept. of Pediatrics, (08/2019) Status: Approved
• Cardiac Graft Failure in Young Adulthood, Role: PI, LLU Dept. of Pediatrics, (10/2024) Status: Approved

Non-Profit Organization

• Integrating Multi-parametric Echocardiography with Computer Assisted Analyses in Detection for Early Allograft Rejection in Pediatric Heart Transplant Recipients: A Pilot Prospective Multicenter Trial, Role: PI, Enduring Hearts Foundation, (06/2020) Status: Approved